During the past decade, National Hospital Organization Kyoto Medical Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 8 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kyoto Medical Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Kyoto University" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kyoto Medical Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kyoto Medical Center" are "Ulcerative Colitis" (7 trials), "Alzheimer Disease" (3 trials), "Gastric Cancer" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "National Hospital Organization Kyoto Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kyoto Medical Center" are "Drug" (23 trials), "Procedure" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (4 trials), "cisplatin" (3 trials), "neoadjuvant therapy" (3 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kyoto Medical Center" are 28 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Kyoto Medical Center". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in National Hospital Organization Kyoto Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kyoto Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".